Latest Period
Q2 2026
Security Snapshot
TEMA ETF TRUST - ONCOLOGY ETF (CANC) Institutional Ownership
CUSIP: 87975E701
13F Institutional Holders and Ownership History from Q4 2023 to Q2 2026
Institutions Reporting
15
Shares (Excl. Options)
505,197
Price
$41.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / ONCOLOGY ETF
- Symbol
- CANC
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 505,197
- Total 13F value
- $20,834,429
- Portfolio coverage rank
- 0%
- Share change
- +5,315
- Value change
- +$630,382
- Number of holders
- 15
- SEC-reported price per share
- $41.30
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CANC - TEMA ETF TRUST - ONCOLOGY ETF is tracked under CUSIP 87975E701.
- 15 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 12 to 15 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $23,468,855 to $20,834,429.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 15 institutions filings for Q2 2026.
Security key
87975E701
Latest holder period
Q2 2026
13F holders
15
13D/G owners
0
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 87975E701:
As of 30 Jun 2026, 15 institutional investors reported holding 505,197 shares of TEMA ETF TRUST - ONCOLOGY ETF (CANC).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q2 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 505,197 | $20,834,429 | +$630,382 | $41.24 | 15 |
| 2026 Q1 | 639,544 | $23,468,855 | -$34,233,798 | $36.70 | 12 |
| 2025 Q4 | 1,572,403 | $54,592,420 | +$46,357,002 | $34.72 | 6 |
| 2025 Q3 | 170,812 | $4,903,210 | -$22,962,319 | $28.70 | 6 |
| 2025 Q2 | 972,874 | $24,053,732 | +$20,692,004 | $24.72 | 5 |
| 2025 Q1 | 135,982 | $3,871,727 | -$11,056,256 | $24.08 | 6 |
| 2024 Q4 | 518,155 | $13,163,730 | +$1,738,694 | $24.50 | 3 |
| 2024 Q3 | 444,457 | $12,627,536 | -$529,413 | $28.41 | 5 |
| 2024 Q2 | 463,083 | $12,493,215 | +$12,262,940 | $26.98 | 4 |
| 2024 Q1 | 8,535 | $239,987 | -$26,093 | $28.12 | 3 |
| 2023 Q4 | 9,463 | $249,798 | +$249,798 | $26.40 | 3 |